Description Belching, bloating, and abdominal distention are all highly prevalent
gastrointestinal symptoms and account for some of the most common reasons for patient …

Abstract Background & Aims Although there have been multiple drugs tested in
gastroparesis, their relative efficacy and safety are unknown. We evaluated this in a network …

Background & Aims Cannabis (delta-9-tetrahydrocannabinol), a nonselective cannabinoid-
receptor agonist, relieves nausea and pain. Cannabidiol (CBD), a cannabinoid receptor 2 …

In this manuscript, we conducted a comprehensive review of the diverse effects of
peppermint on human health and explored the potential underlying mechanisms …

Gastroparesis (GP) is a disorder of gastric functions that is defined by objective delayed
gastric emptying in the absence of mechanical obstruction. This disease is characterized by …

Although there was no significant heterogeneity in the meta-publication, sensitivity analyses
revealed significant heterogeneity. Overall, the prevalence was higher in women (N= 6, R …

Abstract Background/Aim Diabetes has substantive co‐occurrence with disorders of gut‐
brain interactions (DGBIs). The pathophysiological and molecular mechanisms linking …

Disorders of gut–brain interaction (DBGI), also known as functional gastrointestinal
disorders, are common in individuals with eating disorders, and may precede or perpetuate …

Background Drugs which can inhibit nausea/vomiting and/or increase gastric emptying are
used to treat gastroparesis, mostly 'off‐label'. Within each category, they act at different …

Background and aims Diabetic gastroparesis (DGp) is a common and preventable
complication of uncontrolled diabetes mellitus (DM) and significantly affects the quality of life …